Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXP4KC
|
||||
Drug Name |
4-(5-{[3-(3,5-Difluoro-benzyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL165519
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H25F2N5O
|
||||
Canonical SMILES |
Fc1cc(F)cc(CN2CCc3ccccc3C(NCc4cncn4Cc5ccc(cc5)C#N)C2=O)c1
|
||||
InChI |
InChI=1S/C29H25F2N5O/c30-24-11-22(12-25(31)13-24)18-35-10-9-23-3-1-2-4-27(23)28(29(35)37)34-16-26-15-33-19-36(26)17-21-7-5-20(14-32)6-8-21/h1-8,11-13,15,19,28,34H,9-10,16-18H2
|
||||
InChIKey |
VXXYAJGHLFTFPE-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.